Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 1
1997 3
1998 1
1999 4
2000 2
2001 6
2002 5
2003 10
2004 8
2005 5
2006 2
2007 7
2008 9
2009 10
2010 6
2011 5
2012 4
2013 5
2014 1
2015 3
2019 3
2022 3
2024 2
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

98 results

Results by year

Filters applied: . Clear all
Page 1
Aktualisierte S2k-Leitlinie nicht-alkoholische Fettlebererkrankung der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) – April 2022 – AWMF-Registernummer: 021–025.
Roeb E, Canbay A, Bantel H, Bojunga J, de Laffolie J, Demir M, Denzer UW, Geier A, Hofmann WP, Hudert C, Karlas T, Krawczyk M, Longerich T, Luedde T, Roden M, Schattenberg J, Sterneck M, Tannapfel A, Lorenz P, Tacke F; Collaborators:. Roeb E, et al. Z Gastroenterol. 2022 Sep;60(9):1346-1421. doi: 10.1055/a-1880-2283. Epub 2022 Sep 13. Z Gastroenterol. 2022. PMID: 36100202 Free article. German. No abstract available.
Amendment „Neue Nomenklatur zur MASLD (Metabolic Dysfunction Associated Steatotic Liver Disease; metabolische Dysfunktion assoziierte steatotische Lebererkrankung)“ zur S2k-Leitlinie „Nicht-alkoholische Fettlebererkrankung“ (v.2.0/April 2022) der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS).
Roeb E, Canbay A, Bantel H, Bojunga J, de Laffolie J, Demir M, Denzer UW, Geier A, Hofmann WP, Hudert C, Karlas T, Krawczyk M, Longerich T, Lüdde T, Roden M, Schattenberg JM, Sterneck M, Tannapfel A, Lorenz P, Tacke F; Collaborators. Roeb E, et al. Z Gastroenterol. 2024 Jul;62(7):1077-1087. doi: 10.1055/a-2309-6052. Epub 2024 Jul 8. Z Gastroenterol. 2024. PMID: 38976985 German. No abstract available.
[Liver cirrhosis].
Bahr MJ, Manns MP. Bahr MJ, et al. Internist (Berl). 1999 Dec;40(12):1308-22. doi: 10.1007/s001080050470. Internist (Berl). 1999. PMID: 10642918 Review. German. No abstract available.
[Acute liver failure].
Rifai K, Bahr MJ. Rifai K, et al. Among authors: bahr mj. Internist (Berl). 2003 May;44(5):585-90, 592-8. doi: 10.1007/s00108-003-0914-8. Internist (Berl). 2003. PMID: 12966787 Review. German.
[Progress in immunosuppression].
Strassburg CP, Bahr MJ, Becker T, Klempnauer J, Manns MP. Strassburg CP, et al. Among authors: bahr mj. Chirurg. 2008 Feb;79(2):149-56. doi: 10.1007/s00104-007-1456-8. Chirurg. 2008. PMID: 18209989 Review. German.
Membranous Budd-Chiari syndrome in Caucasians.
Ciesek S, Rifai K, Bahr MJ, Boozari B, Steinmann E, Helfritz FA, Wedemeyer H, Manns MP, Lotz J, Gebel M. Ciesek S, et al. Among authors: bahr mj. Scand J Gastroenterol. 2010;45(2):226-34. doi: 10.3109/00365520903406719. Scand J Gastroenterol. 2010. PMID: 19958053
98 results